Cargando…

Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas

Triple-negative breast cancer (TNBC) is an invasive subtype of breast cancer but paradoxically associated with increased tumor-infiltrating leukocytes. The molecular and cellular mechanisms underlying TNBC immunobiology are incompletely understood. Interleukin (IL)-17A is a pro-inflammatory cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dawod, Bassel, Liu, Jinghua, Gebremeskel, Simon, Yan, Chi, Sappong, Antonia, Johnston, Brent, Hoskin, David W., Marshall, Jean S., Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414122/ https://www.ncbi.nlm.nih.gov/pubmed/32770025 http://dx.doi.org/10.1038/s41598-020-70231-7

Ejemplares similares

T(h)17, T(h)22, and Myeloid-Derived Suppressor Cell Population Dynamics and Response to IL-6 in 4T1 Mammary Carcinoma
por: Rasé, Viva J., et al.
Publicado: (2022)

Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production
por: Tachibana, Masashi, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cell-Derived Arginase-1 Oppositely Modulates IL-17A and IL-17F Through the ESR/STAT3 Pathway During Colitis in Mice
por: Ma, Zhanchuan, et al.
Publicado: (2020)

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Cytokines and Soluble Receptors in Breast Milk as Enhancers of Oral Tolerance Development
por: Dawod, Bassel, et al.
Publicado: (2019)

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression
por: Nelson, Adam, et al.
Publicado: (2022)

Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients
por: Darcy, Christabelle J, et al.
Publicado: (2014)

Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers
por: YAZAWA, TAKASHI, et al.
Publicado: (2013)

IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer
por: Chen, Xiaowei, et al.
Publicado: (2015)

Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression
por: Colligan, Sean H., et al.
Publicado: (2022)

Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model
por: Yang, Zhuoshun, et al.
Publicado: (2010)

An Agent-based Model for Investigating the Effect of Myeloid-Derived Suppressor Cells and its Depletion on Tumor Immune Surveillance
por: Allahverdy, Armin, et al.
Publicado: (2019)

Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs
por: Bosiljcic, Momir, et al.
Publicado: (2019)

IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine
por: Roux, Cecilia, et al.
Publicado: (2021)

Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
por: Gebremeskel, Simon, et al.
Publicado: (2015)

Mast Cells and Natural Killer Cells—A Potentially Critical Interaction
por: Portales-Cervantes, Liliana, et al.
Publicado: (2019)

Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers
por: Tang, Yao, et al.
Publicado: (2022)

Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?
por: Wen, Liang, et al.
Publicado: (2016)

Th17/Treg balance is regulated by myeloid‐derived suppressor cells in experimental autoimmune myocarditis
por: Xiong, Xin, et al.
Publicado: (2023)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

IL-12 Enhances Immune Response by Modulation of Myeloid Derived Suppressor Cells in Tumor Microenvironment
por: Choi, Ji-Na, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response
por: Kato, Takuya, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells Promote the Progression of Primary Membranous Nephropathy by Enhancing Th17 Response
por: Li, Huimin, et al.
Publicado: (2020)

IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
por: Tobin, Richard P., et al.
Publicado: (2019)

Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory Monocytes
por: Achmus, Lennart, et al.
Publicado: (2020)

CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
por: Veinotte, Linnea, et al.
Publicado: (2016)

6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice
por: Jeanbart, Laura, et al.
Publicado: (2015)

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication
por: Draghiciu, Oana, et al.
Publicado: (2015)

IL-17F depletion accelerates chitosan conduit guided peripheral nerve regeneration
por: Chen, Feixiang, et al.
Publicado: (2021)

Loss-of-function of the hippo transducer TAZ reduces mammary tumor growth through a myeloid-derived suppressor cell-dependent mechanism
por: Shen, He, et al.
Publicado: (2022)

IL-7 treatment augments and prolongs sepsis-induced expansion of IL-10-producing B lymphocytes and myeloid-derived suppressor cells
por: Kulkarni, Upasana, et al.
Publicado: (2018)

Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Myeloid Derived Suppressor Cells: Fuel the Fire
por: Achyut, B. R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_efc020aktr5kgju1rbrl0ott4j